Pure Global
NCT06091982

Renal Replacement Therapy and In-Hospital Mortality Incidence in Cardiac Surgery Associated Acute Kidney Injury

The Need of Renal Replacement Therapy and In-Hospital Mortality Incidence In Patients With Cardiac Surgery Associated Acute Kidney Injury: Retrospective Study
National Cardiovascular Center Harapan Kita Hospital Indonesia·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Acute Kidney Injury
Drug/Device/Intervention
Renal Replacement Therapy (RRT)
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
National Cardiovascular Center Harapan Kita Hospital Indonesia
Location
Jakarta, Indonesia
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2023
End date
Dec 31, 2023
Enrollment
1113 participants
Primary outcome

Mortality

Summary

The goal of this study is to analyse the relation of severe acute kidney injury post cardiac
 surgery which characterised by the need of renal replacement therapy, with in-hospital
 postoperative mortality incidence.
 
 The main question it aims to answer:
 
 To compare between patients complicated with acute kidney injury and exposure of renal
 replacement therapy (AKI-RRT) and patients complicated with acute kidney injury which does
 not require renal replacement therapy, in associated with in-hospital postoperative
 mortality.

ICD-10 classifications
Injury of kidneyAcute renal failureAcute renal failure, unspecifiedOther acute renal failureAcute renal failure with tubular necrosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06091982
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06091982 through Pure Global AI's free database. This phase not specified trial is sponsored by National Cardiovascular Center Harapan Kita Hospital Indonesia and is currently Recruiting. The study focuses on Acute Kidney Injury. Target enrollment is 1113 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.